NIH-funded research R01 grant

Understanding how stress granules affect leukemia stem cells

Official title: Dissecting stress granule dependencies in leukemia stem cells

Funded at University of California, San Diego · NIH-10877718 · Data updated 2026-11-12

This study is looking at how tiny structures in cells, called stress granules, help leukemia stem cells survive and grow in acute myeloid leukemia, with the hope of finding better treatments for patients like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$432,496
NIH project number5R01CA273432-02
Project IDNIH-10877718 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia, particularly those with treatment-resistant forms of the disease.

Less likely to help

Patients with other types of leukemia or those who are not diagnosed with acute myeloid leukemia may not benefit from this research.

What this research studies

This research investigates the role of stress granules in the survival and proliferation of leukemia stem cells (LSCs) in acute myeloid leukemia (AML). By utilizing advanced genetic screening techniques and in vivo studies, the researchers aim to uncover how these cellular structures contribute to the persistence of treatment-resistant LSCs. The study focuses on the molecular mechanisms that govern RNA metabolism and gene expression in LSCs, which could lead to new therapeutic strategies. Patients may benefit from insights that could improve treatment outcomes for AML.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that specifically target leukemia stem cells, potentially improving survival rates for AML patients.

How similar studies have gone: Other research has shown promising results in targeting RNA metabolism in cancer cells, suggesting that this approach may hold potential for AML treatment.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Yeo, Eugene Wei-Ming — University of California, San Diego
  • Study coordinator: Yeo, Eugene Wei-Ming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.